Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
The Importance of Country Selection in Clinical Study Design
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 420
Date: Thursday, June 27, 2013
Time: 10:45 AM to 12:15 PM  EST
Location: 152
CHAIR :
 Joan M Meyer, (SCHNON), Executive Director, Operational Strategy and Planning, Covance Inc., United States
PANELIST :
Lani Hashimoto, (SPKNON), Hashimoto Consulting Services, United States
SPEAKER :
 Jeffrey S. Handen, PhD (SPKNON), Vice President, Clinical Solutions, Medidata Solutions Worldwide, United States
Description
The importance of country selection as part of the overall clinical trial strategy will be discussed. The impact of country selection on patient recruitment and retention programs and how it impacts a company’s marketing plans will be considered.

Session Recording
(Code: 420)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Handout Online
(Code: 420)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
The Importance of Country Selection in Clinical Study Design